THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

NCT05735639 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

6660

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Varicose Veins

Interventions

DRUG: Dalteparin Sodium
DRUG: Tinzaparin Sodium
DRUG: Enoxaparin Sodium
DRUG: Rivaroxaban
DRUG: Apixaban
DRUG: Dabigatran Etexilate

Sponsor

Imperial College London